Chapter 1: Overview of the M.O.R.E Act

In December 2020, the House of Representatives moved forward with two significant federal bills that advocate for cannabis: the Marijuana Opportunity Reinvestment and Expungement Act, commonly known as the M.O.R.E Act, and the Medical Marijuana Research Act (MMJ Research Act). While the latter focuses on enabling the FDA to conduct comprehensive studies, which could eventually lead to full federal legalization, the M.O.R.E Act has generated considerable enthusiasm and discussion.

The M.O.R.E Act aims to eliminate marijuana's classification as a Schedule I substance. For those unfamiliar with this designation, Schedule I drugs are described by government sources as having no recognized medical use and a high potential for abuse. Examples include heroin, LSD, and marijuana, which many argue are inaccurately grouped with more dangerous drugs. The classification reflects poorly on our government, as it fails to recognize the medicinal value of cannabis compared to substances like methamphetamine and heroin.

In addition to descheduling cannabis, the M.O.R.E Act would also decriminalize marijuana at the federal level, leading to the release of individuals incarcerated for nonviolent marijuana offenses. This change could save taxpayers significant amounts of money currently spent on imprisoning individuals for minor cannabis-related offenses, which disproportionately impacts people of color.

However, the M.O.R.E Act allows states the autonomy to regulate cannabis legalization and integration independently. Thus, it does not imply a nationwide legalization of marijuana, nor does it guarantee the immediate release of all individuals incarcerated for related offenses.

Chapter 2: Legislative Journey of the M.O.R.E Act

Despite the excitement surrounding the M.O.R.E Act, significant hurdles remain. Although the House of Representatives passed the legislation in April 2022, it still requires approval from the Senate and the President. Moreover, legislative processes occur in cycles, meaning the M.O.R.E Act and its counterpart are unlikely to be revisited in the current congressional session.

In essence, a congressional session is an annual meeting of Congress and the Senate to discuss and vote on bills. This session happens once a year, necessitating that the House reconsiders the bills.

The passage of the M.O.R.E Act represents a pivotal moment; it marks the first time in 25 years that Congress has contemplated aligning federal and state cannabis policies. This progress also signifies the first consideration in half a century to remove cannabis from its Schedule I classification, hinting at a more favorable future for marijuana legalization.

The first video titled "4 Act Story Structure Makes More Sense Than 3 Acts - Jeffrey Alan Schechter - YouTube" discusses the storytelling framework that may resonate with those interested in the narrative surrounding cannabis legislation.

Another informative video, "Cutting Red Tape To Build More Homes Act 2024 Breakdown & Its Effects on the Durham Region - YouTube," provides insights into legislative changes that may influence various sectors, including housing and potentially cannabis policy.

In conclusion, although the M.O.R.E Act did not pass in the Senate, there remains hope for future legislative changes. With shifting political landscapes, advocates for cannabis legalization may gain traction as discussions evolve. Thank you for taking the time to read this article; I trust it has provided valuable insights.

For additional reading, consider my fictional fantasy book, "Memoirs of the In-Between," available on Amazon in various formats. Your support through affiliate links helps supplement my family's income; thank you for your continued support.